-
2023
-
Anti-Amyloid-ß Oligomer Antibody ACU193 Gains FDA Fast Track Designation
-
Nona and Dragonfly enter HCAb-based drug discovery partnership
-
FDA Grants Breakthrough Therapy Status to Iveric Bio’s Zimura for AMD
-
Biovac and IVI enter deal to develop oral cholera vaccine
-
New CRISPR-based tool inserts large DNA sequences at desired sites in cells
-
EC grants approval for AbbVie’s Skyrizi to treat Crohn’s disease
-
Senators Introduce New Bill to Promote Research and Access to MDMA, Psilocybin
-
Chemotherapy could increase disease susceptibility in future generations
-
EU launches AI-powered real-world data project for cancer therapies
-
AXS-05 Meets Primary End Point in Phase 3 Trial of Alzheimer Agitation